Application no. and date | 16813299.1 (espacenet) (Federated) (European Patent Register), 20161202 | Patent/reg. no. and date | DK/EP 3383392, 20250709 | Publication date | 20181010 | Priority no. and date | US 201562263554 P, 20151204, US 201662375832 P, 20160816 | EP pub. no. and date |
EP 3383392 20181010 | Effective date | | Applicant/owner | Global Blood Therapeutics, Inc., 181 Oyster Point Blvd.
South San Francisco, CA 94080, US | Applicant ref. no. | V492698DK00 | Inventor | RAMOS, Eleanor, L., c/o Global Blood Therapeutics, Inc. 181 Oyster Point Blvd.
South San Francisco, CA 94080, US, LEHRER-GRAIWER, Joshua, Eli, c/o Global Blood Therapeutics, Inc. 181 Oyster Point Blvd.
South San Francisco, CA 94080, US, HUTCHALEELAHA, Athiwat, c/o Global Blood Therapeutics, Inc. 181 Oyster Point Blvd.
South San Francisco, CA 94080, US, BEJUGAM, Naveen, c/o Global Blood Therapeutics, Inc. 181 Oyster Point Blvd.
South San Francisco, CA 94080, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/4439 (2006.01) , A61K 9/48 (2006.01) , A61P 35/02 (2006.01) | Title | Doseringsskema for 2.HYDROXY.6.((2.(1.ISOPROPYL.1H.PYRAZOL.5.YL)PYRIDIN.3.YL)METHOXY)BENZALDEHYD | Int. application no. | US2016064723 | Int. publication no. | WO2017096230 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|